DSGN · Design Therapeutics, Inc. · Executive Compensation
Market Cap
$915.57M
Shares
62.58M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Pratik Shah | President, Chief Executive Officer and Chairperson | $3,544,300 |
| Chris M. Storgard | Chief Medical Officer | $2,030,270 |
| Sean Jeffries | Chief Operating Officer | $1,891,530 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Sean Jeffries | Chief Operating Officer | $1,315,002 |
| Pratik Shah | President, Chief Executive Officer and Chairperson | $789,800 |
| Jae B. Kim | Former Chief Medical Officer | $710,651 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Pratik Shah | President, Chief Executive Officer and Chairperson | $6,317,780 |
| João Siffert | Former President and Chief Executive Officer | $3,512,825 |
| Sean Jeffries | Chief Operating Officer | $1,283,615 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| João Siffert | Former President and Chief Executive Officer | $4,779,555 |
| Pratik Shah | President, Chief Executive Officer and Chairperson | $4,515,565 |
| Sean Jeffries | Chief Operating Officer | $3,429,024 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| João Siffert | President and Chief Executive Officer | $933,000 |
| Pratik Shah | Executive Chairperson | $585,030 |
| Sean Jeffries | Chief Operating Officer | $476,000 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| João Siffert | President and Chief Executive Officer | $4,357,343 |
| Pratik Shah | Executive Chairperson | $400,000 |
| Sean Jeffries | Chief Operating Officer | $343,333 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| David Shapiro, M.D. | Class III director | Appointed | 2026-04-01 |
| Deepa Prasad | Board of Directors | Resigned | 2026-01-30 |
| Justin Gover | Class III director | Appointed | 2025-09-10 |
| Justin Gover | chair of the Compensation Committee of the Board | Appointed | 2025-09-10 |
| Arsani William, M.D. | member of the board of directors | Resigned | 2025-09-10 |
Key facts
CIK
1807120
CUSIP
25056L103
13F (30d)
80 filings
80 filers
Visit website
Investor relations